Cargando…
Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is a major subtype of non-small cell lung cancer (NSCLC) with a highly heterogeneous tumor microenvironment. Immune checkpoint inhibitors (ICIs) are more effective in tumors with a pre-activated immune status. However, the potential of the immune activation-ass...
Autores principales: | Zeng, Weibiao, Wang, Jin, Yang, Jian, Chen, Zhike, Cui, Yuan, Li, Qifan, Luo, Gaomeng, Ding, Hao, Ju, Sheng, Li, Baisong, Chen, Jun, Xie, Yufeng, Tong, Xin, Liu, Mi, Zhao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364982/ https://www.ncbi.nlm.nih.gov/pubmed/37492563 http://dx.doi.org/10.3389/fimmu.2023.1217590 |
Ejemplares similares
-
Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma
por: Cui, Yuan, et al.
Publicado: (2022) -
Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
por: Yang, Jian, et al.
Publicado: (2022) -
Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
por: Yang, Jian, et al.
Publicado: (2022) -
Integration of single-cell and bulk RNA-seq to establish a predictive signature based on the differentiation trajectory of M2 macrophages in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2022) -
SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2023)